Profiel
Christopher M.
Murphy is Chief Financial Officer at AnaptysBio, Inc. since 2026.
Formerly, Mr. Murphy was Treasurer, Chief Financial & Business Officer at Third Harmonic Bio, Inc. from 2024 to 2025.
From 2014 to 2020, Mr. Murphy was Group Vice President-Commercial Operations at Horizon Therapeutics Ltd. (Ireland) from 2018 to 2020.
Mr. Murphy completed undergraduate studies at the University of Notre Dame.
Actieve functies van Christopher Murphy
| Bedrijven | Functie | Begin |
|---|---|---|
| ANAPTYSBIO, INC. | Financieel Directeur/CFO | 11-05-2026 |
Eerdere bekende functies van Christopher Murphy
| Bedrijven | Functie | Einde |
|---|---|---|
| THIRD HARMONIC BIO, INC. | Financieel Directeur/CFO | 01-12-2025 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01-05-2020 |
Opleiding van Christopher Murphy
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AnaptysBio, Inc.
AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Third Harmonic Bio, Inc.
Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
















